$CCCC
C4 Therapeutics, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$3.39
▼-0.73%-$0.025
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateC4 Therapeutics, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CCCC down today? It is at $3.39 (-0.73%), and our scanner flagged it 84 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CCCC spikes, and full due diligence on CCCC — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CCCC 84 times in the last 30 days. Create a free account to track $CCCC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CCCC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CCCC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Reyno Leonard Officer | Sold (automatic/other) | -7K | sold 1.9% | 372K | $30K at $4.06 | Jul 10, 26 |
Reyno Leonard Officer | Other | 15K 0.01% of company | added 4.2% | 380K | n/a | Jul 10, 26 |
Anderson Kenneth Carl Director | Acquired (grant/award) | +3K | added 3.8% | 72K | $12K at $4.34 | Jul 1, 26 |
Grogan Donna Roy Director | Acquired (grant/award) | +3K | added 4.7% | 75K | $14K at $4.34 | Jul 1, 26 |
Anderson Kenneth Carl Director | Other | 1K | added 1.6% | 69K | $2K at $2.11 | Jun 1, 26 |
Grogan Donna Roy Director | Acquired (grant/award) | +5K | added 8.1% | 72K | $14K at $2.70 | Apr 1, 26 |
Anderson Kenneth Carl Director | Acquired (grant/award) | +4K | added 6.7% | 68K | $11K at $2.70 | Apr 1, 26 |
Hirsch Andrew Officer | Sold (automatic/other) | -9K | sold 0.8% | 1.07M | $17K at $1.89 | Feb 15, 26 |
Hirsch Andrew Officer | Other | 20K 0.02% of company | added 1.9% | 1.08M | n/a | Feb 15, 26 |
Adams Kendra Officer | Sold (automatic/other) | -15K 0.01% of company | sold 3.8% | 385K | $29K at $1.89 | Feb 14, 26 |
Adams Kendra Officer | Other | 31K 0.03% of company | added 8.4% | 400K | n/a | Feb 14, 26 |
Mossler Mark Officer | Sold (automatic/other) | -3K | sold 4.3% | 72K | $6K at $1.89 | Feb 14, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CCCC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CCCC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CCCC last traded at $3.39, down 0.73% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
C4 Therapeutics, Inc. (CCCC) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CCCC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CCCC 84 times in the last 30 days.
CCCC (C4 Therapeutics, Inc.) trades on XNAS, with a market cap of about $417M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CCCC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CCCC discussion
Sign in to ask a question or join the discussion.